$18.60
+0.70 (+3.88%)
Performance
1D
-0.59%
1W
-5.05%
1M
-3.68%
3M
-27.60%
6M
-19.13%
1Y
+22.05%
YTD
-10.66%
Open$18.16
Previous Close$17.91
Day High$18.97
Day Low$17.32
52W High$30.06
52W Low$14.64
Volume—
Avg Volume1.64M
Market Cap2.22B
P/E Ratio—
EPS$-2.51
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$21.49
Below
SMA 200
$22.37
Below
RSI (14)
61.3
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+606.9% upside
Current
$18.60
$18.60
Target
$131.49
$131.49
$82.08
$131.49 avg
$141.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.47M | 603.96M | 550.96M |
| Net Income | -289,778,417 | -173,219,826 | -162,867,502 |
| Profit Margin | -3,060.0% | -28.7% | -29.6% |
| EBITDA | -302,399,242 | -273,358,868 | -247,027,649 |
| Free Cash Flow | — | -130,399,233 | -192,377,550 |
| Rev Growth | — | +13.0% | +19.7% |
| Debt/Equity | — | 0.20 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |